Harm reduction in jails protects lives and communities

Opioid dependence is a complex health condition, not a moral failure. It can arise through chronic pain, prescribed medicines, illicit opioids or a mixture of lived circumstances. People who use opioids face elevated overdose risk in custody and soon after release, particularly when treatment is interrupted and tolerance drops. A jail-based harm reduction program for opioid users responds to that risk with practical health care rather than punishment alone.

At its best, such a program provides naloxone, opioid agonist treatment, confidential screening and trusted peer support. It also prepares people for a return to the community by arranging medication, primary care, housing assistance and emergency contacts. Harm reduction does not mean ignoring exploitation or unsafe supply; it means reducing the chance of death, infection and trauma while keeping people engaged in care.

Australians will recognise many of the same barriers. The country’s adult correctional facilities are usually called prisons, but police lockups and short-stay custodial settings can create the same abrupt transitions. In New South Wales, take-home naloxone is supplied through participating pharmacies, and Victoria has expanded pharmacy and harm-reduction access. Someone leaving custody in Sydney or Melbourne late in the week may still face a weekend gap in treatment, transport, support and suitable accommodation.

A sound local response must also account for the over-representation of Aboriginal and Torres Strait Islander people in Australian prisons, while respecting culture, kinship and choice. State bail and sentencing laws, including New South Wales’s Bail Act 2012, can shape who enters and leaves custody and for how long. Each of those systems changes the health risks surrounding opioid use, making coordination across justice, health and housing essential.

Custody can magnify an existing overdose risk

Opioid intoxication, chronic illness and withdrawal may be poorly identified on entry. In some facilities, people arrive without a reliable medication history and experience painful or untreated withdrawal. If illicit opioids are used during custody, reduced tolerance can make the same amount far more potent when a person returns home. Release after weeks or months may bring the greatest danger because usual supply patterns and dosing are no longer predictable.

That risk is tied to how the justice system responds to offending. The coalition’s Louisiana review of mandatory minimum sentencing explains how fixed terms can increase exposure to incarceration and release without solving addiction, trauma or social instability. Longer periods in custody must be paired with reliable treatment, not treated as a substitute for it.

Australian systems do not mirror Louisiana’s statutes, and the comparison should not be blurred. The relevant lesson is simpler: policy choices have health consequences. Prison health teams, alcohol and other drug services, and Aboriginal community-controlled organisations need timely access when a person is admitted, transferred or discharged.

Core services that prevent immediate harm

Overdose readiness should begin at intake. People should be asked about current medicines, opioid use, previous overdoses and where they obtain care, with private interviews and clear consent. Naloxone should be available to those at risk, and staff should be trained to recognise and respond to an overdose. Take-home naloxone on release closes a critical gap while familiarising the person and their family with its use.

Opioid agonist treatment with methadone or buprenorphine is central for many participants because it manages withdrawal, lowers overdose risk and creates a stable contact with care. Treatment should continue through booking, transport and arrival at the receiving service. Voluntary counselling, harm-reduction education and sterile equipment where permitted complement, rather than replace, good medication treatment.

Fentanyl and other unregulated opioids require messages that do not imply every substance is the same. Drug checking, where authorised, can offer another way to discuss unexpected substances without punishing the person for seeking information. Across Australia, access rules differ between prisons, public health services and community pharmacies, so a consistent protocol matters.

Continuity of care beyond the prison gate

The first appointment after release should not be a vague referral. A named worker can confirm that the person has medication, naloxone, identification and somewhere safe to travel. If no appointment is available, the program can contact a local public clinic or Aboriginal medical service. A delayed appointment is not a neutral administrative problem during post-custody tolerance reduction; it can become fatal.

Australian community treatment already depends on pharmacies, public clinics and specialist services. The Therapeutic Goods Administration regulates medicines, while the Pharmaceutical Benefits Scheme and state programs shape subsidised access. Dosing at a community pharmacy may be routine in a capital city, yet transport from an outer suburb or regional town can still disrupt it. Medically supervised take-home options can prevent a missed dose without increasing unsafe use.

Continuity also protects against infections and untreated chronic conditions. Vaccination, hepatitis C treatment, HIV prevention, wound care and mental-health support should be coordinated with opioid treatment. This joined-up approach gives people a better chance of keeping appointments, managing pain and avoiding a return to uncontrolled use.

What the program delivers in practice

A workable service becomes easier to understand when its responsibilities are visible at both ends of custody.

Immediate safety measures

• A private health and substance-use assessment, repeated when circumstances change.
• Naloxone access, overdose-response training and a documented staff escalation plan.
• Uninterrupted methadone or buprenorphine, without punishment for treatment lapses.
• A peer worker who can explain rights, choices and harm-reduction options.

Release planning needs equally specific ownership and handover arrangements.

• A medication supply and naloxone where clinically indicated, with plain-language instructions.
• A booked appointment or an assured bridge to treatment when the usual provider is closed.
• Transport, accommodation or financial assistance arranged before the person leaves custody.
• Consent-based contact with a family member, treatment service or support worker.

Benefits for families and neighbourhoods

Keeping someone alive allows families to continue caring for children, paying bills and making plans beyond a crisis. It can also reduce emergency ambulance calls, naloxone use and the psychological burden carried by relatives. After release, fewer overdoses create more time for stable treatment and housing, while safer prescribing and effective addiction care can ease pressure on local health services.

Housing is a health intervention, not an optional extra. The coalition’s Louisiana reporting on criminal-record screening shows how a conviction can block a suitable home and expose someone to unsafe environments or rough sleeping. Australian tenancy law and privacy rules differ by state and territory, but landlords and screening providers still need fair, consistent criteria that do not turn a past sentence into permanent exclusion.

Designing for dignity, safety and cultural connection

Aboriginal and Torres Strait Islander people should help determine how any local program is designed and assessed. That means involving Aboriginal health staff, Elders and community-controlled services wherever possible, with interpreters and disability supports available. Cultural connection, family contact and quiet space can improve cooperation without making Indigenous identity itself a source of suspicion.

The same standards apply to everyone in custody. Consent, privacy and trauma-informed care matter for people with mental illness, disability, language needs or a history of assault. Searches, isolation and medication decisions should follow transparent procedures, while complaints should reach an independent reviewer. Human dignity often makes disclosure, trust and cooperation safer.

At parish level in Louisiana, public oversight, humane treatment and rehabilitation are central demands for the East Baton Rouge Parish Prison Reform Coalition. Its advocacy illustrates how families, clinicians and civil-rights groups can scrutinise conditions hidden from the public. Local oversight must pair access with clear data on medication continuity, overdoses, treatment uptake and deaths after release.

The need for a trusted local contact appears beyond corrections as well. Fundacja Karpacka is an international example of a clearly identified community organisation helping people find practical support. In a prison setting, an equivalent role can be filled by an independent peer navigator who speaks the person’s language and remains contactable after release.

A practical test for safer release

A program should start with a service map: which clinic will accept a released person after hours, which pharmacy supplies medication, who holds naloxone and what transport is available. A small pilot can then test intake assessment, same-day treatment, peer follow-up and data sharing. Staff need written responsibilities, escalation routes and regular review, especially when health and custodial systems use separate records.

Evaluation should track deaths and overdoses, retention in treatment, medication interruptions, naloxone provision, infectious-disease care and housing outcomes. It should also ask whether people report respectful treatment and whether Aboriginal community-controlled services are involved. These measures reveal whether a program changes everyday life or merely records that supplies were distributed.

The financial case is strongest when reduced emergency care, prison admissions and repeated treatment disruption are considered alongside the cost of medicines and staff time. Early support is also more humane than responding to an avoidable death. The practical takeaway is to treat entry medication, overdose readiness and release continuity as one connected pathway: jail doors should not create a gap in lifesaving care.